CORMEDIX INC. - COMMON STOCK

CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10

02 ноя 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference

20 окт 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference

07 сен 2022 08:30:01 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

11 авг 2022 07:30:01 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Regulatory and Manufacturing Updates

08 авг 2022 16:05:02 Источник Nasdaq GlobeNewswire

CorMedix to Participate at the JMP Securities Life Sciences Conference

08 июн 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

12 май 2022 16:01:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Leadership Updates and Operational Changes

12 май 2022 08:30:01 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12

03 май 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development

07 апр 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference

04 апр 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

29 мар 2022 16:01:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath

28 мар 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results and Provide a Corporate Update on March 29

22 мар 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces the Appointment of Chief Executive Officer

17 мар 2022 08:30:00 Источник Nasdaq GlobeNewswire

Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath

28 фев 2022 08:30:00 Источник Nasdaq GlobeNewswire

CorMedix to Participate in Upcoming January Conferences

04 янв 2022 08:00:02 Источник Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

09 ноя 2021 16:05:02 Источник Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9

02 ноя 2021 08:30:01 Источник Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI

20 окт 2021 08:30:00 Источник Nasdaq GlobeNewswire